Avonex interferon beta-1a: Phase IV data

Biogen Idec reported data from the 15-year, open-label Phase IV ASSURANCE study in 103 patients who were previously treated for at least 2 years with Avonex or placebo in the Phase III MSCRG trial. Fe...